ERAS Swallowing Rehabilitation in Elder Patients
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Aug 13, 2023
Trial Information
Current as of November 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The ERAS Swallowing Rehabilitation trial is looking at how a special training program can help older patients recover their swallowing ability more quickly after surgery. This program, called the Early Recovery Accelerated Swallowing (ERAS-W program), starts before the surgery and continues afterward. The researchers want to see if patients who participate in this program will have better swallowing function compared to those who do not receive the training.
To be eligible for this study, participants should be having elective surgery that requires general anesthesia with a breathing tube. However, those with serious health issues, such as severe kidney problems or heart failure, or those with a tendency to bleed easily, will not be able to join. This trial has not started recruiting participants yet, but it aims to help improve recovery for older patients facing surgery, making the process smoother and safer for them.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • elective surgery
- • general anesthesia with endotracheal intubation
- Exclusion Criteria:
- • major organ dysfunction, ex: chronic kidney disease, hear failure
- • bleeding tendency
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported